HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Peanut Protein Power: Health And Wellness New Products Roundup

This article was originally published in The Rose Sheet

Executive Summary

Klean offers creatine; energize with vapor; manuka oil blend tests well; Solix offers another astaxanthin; and more news in brief.

You may also be interested in...



Skin Care Line First For New Chapter Founder Schulick, Nutraceuticals In 2020

New Chapter founder Paul Schulick will introduce skin masks, cleansers and lotions with Algatech's topical astaxanthin to maintain skin microbiome. He also plans to launch nutraceuticals once a non-compete agreement with P&G, the owner of his former firm New Chapter, expires in 2020.

NY Proposal To Age-Restrict Creatine Sales Draws CRN Criticism

CRN argues that legislation a New York state assembly member authored to ban sales of supplements to consumers younger than 18 would restrict the sale of the supplements to all consumers.

Limiting Sport Supplement Sales To Minors Recommended By More Researchers

More than two-thirds of health food stores’ staff recommended creatine to researchers posing as teen athletes, results that researchers say should prompt pediatricians and retailers to educate young people on the risk of creatine and push states to ban sales of the substance to minors.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108961

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel